# Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients

> **NCT06182917** · — · RECRUITING · sponsor: **West China Second University Hospital** · enrollment: 35 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06182917
- **Lead sponsor:** West China Second University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2023-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06182917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06182917, "Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06182917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*